Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Saquinavir:MCnc:Pt:Ser/Plas:Qn

Known as: Saquinavir:Mass Concentration:Point in time:Serum/Plasma:Quantitative, Saquinavir [Mass/volume] in Serum or Plasma, Saquinavir:MCnc:Pt:Sor/Plas:Qn 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
BACKGROUND A saquinavir/ritonavir-containing regimen is one option for the prevention of mother-to-child transmission of HIV… Expand
  • table 1
  • figure 1
  • table 2
Is this relevant?
2006
2006
ContextOnce-daily HIV treatment regimens are being used in clinical practice with the objective of improving patient acceptance… Expand
  • table 1
  • table 2
Is this relevant?
2005
2005
OBJECTIVE To assess the pharmacokinetics and 24-week efficacy and safety of dual boosted saquinavir/lopinavir/ritonavir… Expand
Is this relevant?
2005
2005
OBJECTIVES To assess the efficacy and safety of a once-daily regimen with didanosine, lamivudine, saquinavir, and low-dose… Expand
Is this relevant?
2001
2001
Risk factors in the development of adverse reactions in HIV-1-infected patients treated with highly active antiretroviral therapy… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
OBJECTIVE To determine the predictors of virological and clinical failure in patients receiving a protease inhibitor as part of… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
OBJECTIVE To assess the probability that protease inhibitor (PI) therapy might be discontinued because of adverse events (AE) and… Expand
Is this relevant?
2000
2000
Human immunodeficiency virus type 1 (HIV-1) protease inhibitors have dramatically improved treatment options for HIV infection… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2000
2000
Amprenavir (Agenerase, 141-W94, VX-478) is a human immunodeficiency virus type 1 (HIV-1) protease inhibitor (PRI) recently… Expand
Is this relevant?
1999
1999
ObjectiveThe aim of this study was to confirm the most appropriate dosage of a new soft gelatin capsule (SGC) formulation of the… Expand
Is this relevant?